atopic dermatitis

Saplings growing with increasing denominations of money wrapped around them
Biotech

Regeneron backs $75M series A for antibody upstart Infinimmune

The raise will support two eczema drugs that Infinimmune plans to push into the clinic next year.
Darren Incorvaia Aug 11, 2026 8:00am
Sanofi

Sanofi won't seek approval for eczema drug from Kymab buyout

Jul 24, 2026 5:13am
IPO initial public offering

Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

Jul 15, 2026 4:09am
IPO

Talawar heads to Nasdaq via SPAC deal to fund eczema bispecific

Jun 29, 2026 7:00am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

AbbVie inks $10.9B Apogee buyout to bag eczema prospect

Jun 22, 2026 7:59am
sailing boat water yacht ocean wind

Windward breezes toward phase 3 with $165M for TSLP ambitions

May 4, 2026 10:31am